|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Treatment of the elderly w/ some degree of cerebral functional impairment such as loss of memory, lack of conc or alertness, mood changes, vertigo, personal negligence & deterioration in behaviour. Treatment of symptoms related to chronic alcoholism w/drawal & of chronic alcoholic patients suffering from a psycho organic brain syndrome. Treatment of coma of vascular, traumatic or toxic origin, as well as cognitive deficit &/or vertigo resulting from head injury. Patients suffering from myoclonus of cortical origin, (used in combination w/ other anti-myoclonic therapies).
Cerebral haemorrhage, end stage renal disease.
The side effects reported in connection with THIS MEDICINE include nervousness, agitation, irritability, anxiety and sleep disturbances. The incidence of these during clinical trials was ≤5% and they were more often noted in the older patients taking >2.4 g daily. In the majority of cases, a dose reduction sufficed to make these symptoms disappear. Some patients may complain of fatigue or drowsiness. Gastrointestinal problems eg, nausea, vomiting, diarrhea and stomachache have also been reported, but their incidence during clinical trials was ≤2%. Other symptoms eg, vertigo, headaches, trembling and sexual stimulation have occasionally been reported.
The classical treatment for alcoholism ie, vitamins and sedatives, may continue to be prescribed during cures for alcoholism, in cases where there is a known vitamin deficiency or severe excitability. Only 1 case of interaction has been reported, where THIS MEDICINE and thyroid extract (T3 and T4) were given together and confusion, irritability and sleep disturbances were later observed.
Renal insufficiency (CrCl <80 mL/min), underlying haemostatic disorders, major op or severe haemorrhage. Long-term treatment in elderly, abrupt discontinuation in myoclonic patients.
SOLUTION FOR INJECTION
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Talal Sabouni
Samir Moussa M.D.
Dr. Samer Al-Jneidy
Dr. Faisal Dibsi
Dr. Tahsin Martini
Dr . Dirar Abboud
Yaser Habrawi , F.R.C.S.Ed
Dr. Hani Najjar